Ficonalkib (SY-3505) in Advanced ALK-Positive NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 1/2 Study.
JOURNAL OF THORACIC ONCOLOGY（2024）
Key words
Ficonalkib,Anaplastic lymphoma kinase,Tyro- sine kinase inhibitor,Non-small cell lung cancer,Phase 1/2 study
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined